glp-1-directed nmda receptor antagonism for obesity treatment Targeting Obesity: GLP-1R, GIPR, GDF8 as Key Therapeutic Agents Frontiers | The agony and
Pay in 4 interest-free payments of $6.41 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29































